HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed biopharmaceutical industry veteran Christopher Kiritsy to its Board of Directors...
Login to comment.